the global Nicotinamide Mononucleotide (NMN) market size is projected to reach USD 0.71 billion by 2029

Nicotinamide Mononucleotide (NMN) Market Summary

Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.

• PictureofNicotinamide Mononucleotide (NMN)

Source: GlobalInfoResearch, “Global Nicotinamide Mononucleotide (NMN) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029”(NMN) Market Report 2023-2029.

According to the new market research report “Global Nicotinamide Mononucleotide (NMN) Market Report 2023-2029”, published by GlobalInfoResearch, the global Nicotinamide Mononucleotide (NMN) market size is projected to reach USD 0.71 billion by 2029, at a CAGR of 12.6% during the forecast period.

• Global Nicotinamide Mononucleotide (NMN) MarketSize(US$ Million), 2018 VS 2022 VS 2029

Source: GlobalInfoResearch, “Global Nicotinamide Mononucleotide (NMN) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029”(NMN) Market Report 2023-2029.

Market Drivers:

D1: With the continuous improvement of people's health standards, the big health industry will keep growing for a long time.

D2: Improvement and optimization of production equipment and process.

D3: It is an inevitable law of historical development that new scientific and technological products move from high-end market to popularization. In the next few years, with the further reduction of raw material cost, it will soon become a mass daily consumer goods.

Restraint:

R1: High risks involved consumers in developing countries have weak awareness of use and demand is lower than in developed countries in the world.

R2: There are many barriers for entering into this industry, like capital, equipment, R&D and manufacturing technology, etc.

R3: Large companies dominate high-end market and upstream players extend downward supply chain.

R4: Significantly affected by upstream raw material prices.

R5: Most NMN production capacity in the market comes from China, but NMN and related products have not been registered as health food in China. NMN producers in China will export them to countries and regions with relatively loose supervision, such as Europe, America, Japan and Hong Kong.

Industry Trends:

T1: The downstream market of the product is more abundant, and products with better performance should be developed for different use occasions.

T2: The industry is becoming more and more competitive. As an anti-aging health care product, NMN is expected to have a potential market size of 100 billion in the future, and the current market has just started.

T3: Demand in developing countries is growing rapidly, and leading giants have proposed expansion plans to increase production bases.

T4: Can expect the application of nicotinamide mononucleotide in medicine.

• Global Nicotinamide Mononucleotide (NMN) Top9 Players Rankingand Market Share（Continually updated）

Source: GlobalInfoResearch, “Global Nicotinamide Mononucleotide (NMN) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029”(NMN) Market Report 2023-2029.

According to GlobalInfoResearch Top Players Research Center, the global key manufacturers of Nicotinamide Mononucleotide (NMN) include GeneHarbor, Mirailab Bioscience, EffePharm, Herbalmax, Genex Formulas, etc. In 2022, the global top four players had a share approximately 85.0% in terms of revenue.

Contact Us:

If you have any questions or have further requirements about this report, please contact us.

GlobaI Info Research Co.,Ltd

Web: https://www.globalinforesearch.com

CN: 0086-176 6505 2062

HK: 00852-5808 0956

US: 001-347 966 1888

Email: report@globalinforesearch.com

About Global Info Research

Global Info Research is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.

Global Info Research has more than 30000 global well-known customers, covering more than 30 industries, research regions cover China,Japan,Korea,US,EU,Asia,Middle East and Africa,South America,Australia,etc.